Abstract: A fertilizer delivery device which includes a fertilizer chamber having an open top and an enclosed bottom having a plurality of openings, and a hollow compartment (having an open top and an opened bottom end) that is contained within, and completely surrounded by, the fertilizer chamber. A fertilizer delivery kit is also disclosed which includes the fertilizer delivery device and one or more containers that fit into the hollow compartment of the fertilizer delivery device. In addition, a method of for enhancing and accelerating the production of produce on produce bearing plants is disclosed.

Abstract: A disposable absorbent article defining an absorbent chassis adapted to wrap around portions of a torso and a pair of side panels adapted to secure the absorbent chassis about the torso during use. The side panels include at least a pair of substantially inextensible zones and a zone of substantial elasticity providing partial extensiblity to the side panels. The side panels may be secured to the chassis at one of the inextensible zones and be provided with a fastener component at another inextensible zone. At least portions of opposed edges of the side panels are shaped into a nonparallel configuration to improve fit, comfort and exudate control of the absorbent article.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds having the following structure: wherein A, B, R, R1, R1? p and q are as defined herein. The invention is also directed to pharmaceutical compositions containing one or more of these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds having the following structure: wherein A, B, R, R1, R1? p and q are as defined herein. The invention is also directed to pharmaceutical compositions containing one or more of these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.

Abstract: This invention is directed to novel oxamyl dipeptide ICE/ced-3 family inhibitor compounds. The invention is also directed to pharmaceutical compositions containing these compounds, as well as to the use of such compositions in the treatment of patients suffering inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury, and for the preservation of organs that are to undergo a transplantation procedure.